Ataciguat — Topline data
H1 2027
The Company expects to share Phase 2b topline data from the interim 24-week analysis in the first half of 2027.Source filing
KARD biotech catalysts & pipeline
KARDIGAN INC · Data as of 2026-09-08
Upcoming catalysts
Danicamtiv — Topline data
H1 2027
The Company expects to share Phase 2b topline data in the first half of 2027.Source filing
Tonlamarsen — Topline data
H1 2027
In the second quarter, the Company randomized the first patient in KARDINAL-ASH and expects to share Phase 2 topline data in the first half of 2027.Source filing